Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban for acute non-thrombolytic ischemic stroke
ChiCTR1900025466Phase 4Recruiting
- Sponsor
- Weihai Central Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tirofiban in ischemic stroke (2 arms), sponsored by Weihai Central Hospital. Primary endpoints: Modified Rankin Scale score at 90 days, Incidence of symptomatic intracranial hemorrhage within 48 hours and 1 more. Started Oct 2019; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900025466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025466.